Green Alpha Advisors, LLC Beam Therapeutics Inc. Transaction History
Green Alpha Advisors, LLC
- $112 Million
- Q4 2024
A detailed history of Green Alpha Advisors, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Green Alpha Advisors, LLC holds 10,192 shares of BEAM stock, worth $264,176. This represents 0.23% of its overall portfolio holdings.
Number of Shares
10,192
Previous 12,475
18.3%
Holding current value
$264,176
Previous $305,000
17.38%
% of portfolio
0.23%
Previous 0.25%
Shares
11 transactions
Others Institutions Holding BEAM
# of Institutions
235Shares Held
75.7MCall Options Held
438KPut Options Held
232K-
Farallon Capital Management LLC San Francisco, CA8.21MShares$213 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.84MShares$203 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$198 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.53MShares$169 Million1.52% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.83MShares$125 Million71.21% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.82B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...